The chromogranins: Their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia (original) (raw)

• Banks P, Helle K. The release of protein from the stimulated adrenal medulla. Biochem J 97:40C-41C, 1965.
  Article PubMed Central CAS PubMed Google Scholar
• Kirshner N, Sage HJ, Smith WJ, et al. Release of catecholamines and specific protein from adrenal glands. Science 154:529–531, 1966.
  Article CAS PubMed Google Scholar
• Banks P, Helle KB, Mayor D. Evidence for the presence of a chromogranin-like protein in bovine splenic nerve granules. Mol Pharmacol 5:210–212, 1968.
  Google Scholar
• Blaschko H, Comline RS, Schneider FH, et al. Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature 215:58–59, 1967.
  Article CAS PubMed Google Scholar
• Cohn DV, Morrissey JJ, Hamilton JW, et al. Isolation and partial characterization of secretory protein I from bovine parathyroid glands. Biochemistry 20:4135–4140, 1981.
  Article CAS PubMed Google Scholar
• Cohn DV, Zangerle R, Fischer-Colbrie R, et al. Similarity of secretory protein I from parathyroid gland to chromogranin A from adrenal medulla. Proc. Natl Acad Sci USA 79:6056–6059, 1982.
  Article PubMed Central CAS PubMed Google Scholar
• Iacangelo A, Affolter HU, Eiden LE, et al. Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues. Nature 323:82–86, 1986.
  Article CAS PubMed Google Scholar
• O'Connor DT. Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum. Regul Pep 6:263–280, 1983.
  Article Google Scholar
• Fischer-Colbrie R, Lassmann H, Hagn C, et al. Immunological studies on the distribution of chromogranin A and B in endocrine and nervous tissues. Neuroscience 16:547–555, 1985.
  Article CAS PubMed Google Scholar
• Fischer-Colbrie R, Hagn C, Kilpatrick L, et al. Chromogranin C: a third component of the acidic proteins in chromaffin granules. J Neurochem 47:318–321, 1986.
  Article CAS PubMed Google Scholar
• Rosa P, Hille A, Lee RWH, et al. Secretogranins I and II: two tyrosine-sulfated secretory proteins common to a variety of cells secreting peptides by the regulated pathway. J Cell Biol 101:1999–2011, 1985.
  Article CAS PubMed Google Scholar
• Eiden LE, Huttner WB, Mallet J, et al. A nomenclature proposal for the chromogranin/secretogranin proteins. Neuroscience 21:1019–1021, 1987.
  Article CAS PubMed Google Scholar
• Helle KB, Aunis D, eds. Chromogranins: functional and clinical aspects. New York: Kluwer Academic/Plenum, 2000; 404.
  Google Scholar
• Fischer-Colbrie R, Eder S, Lovisetti-Scamihorn P, et al. Neuroendocrine secretory protein 55: a novel marker for the constitutive secretory pathway. Ann NY Acad Sci 971:317–322, 2002.
  Article CAS PubMed Google Scholar
• Hashimoto S, Fumagalli G, Zanini A, et al. Sorting of three secretory proteins to distinct secretory granules in acidophilic cells of cow anterior pituitary. J Cell Biol 105:1579–1586, 1987.
  Article CAS PubMed Google Scholar
• Natori S, Huttner WB. Chromogranin B (secretogranin I) promotes sorting to the regulated secretory pathway of processing intermediates derived from a peptide hormone precursor. Proc Natl Acad Sci USA 93:4431–4436, 1996.
  Article PubMed Central CAS PubMed Google Scholar
• Jain RK, Joyce PBM, Gorr S-U. Aggregation chaperones enhance aggregation and storage of secretory proteins in endocrine cells. J Biol Chem 275:27,032–27,036, 2000.
  Article CAS Google Scholar
• Gorr S-U, Jain RK, Kuehn U, et al. Comparative sorting of neuroendocrine secretory proteins: a search for common ground in a mosaic of sorting models and mechanisms. Mol Cell Endocrinol 172:1–6, 2001
  Article CAS PubMed Google Scholar
• Kim T, Tao-Cheng J-H, Eiden LE, et al. Chromogranin A, an “on/off” switch controlling dense-core secretory granule biogenesis. Cell 106:1–13, 2001.
  Article Google Scholar
• Reiffen FU, Gratzl M. Chromogranins, widespread in endocrine and nervous tissue, bind Ca2+ FEBS Lett 195:327–330, 1986.
  Article CAS PubMed Google Scholar
• Yoo SH, Albanesi JP. High capacity, low affinity Ca2+ binding of chromogranin A. J Biol Chem 266:7740–7745, 1991.
  CAS PubMed Google Scholar
• Yoo S-H. pH- and Ca2+-induced conformational change and aggregation of chromogranin B: comparison with chromogranin A and implication in secretory vesicle biogenesis. J Biol Chem 270:12,578–12,583, 1995.
  Article CAS Google Scholar
• Gerdes H-H, Rosa P, Phillips E, et al. The primary structure of human secretogranin II, a widespread tyrosine-sulfared secretory granule protein that exhibits low pH- and calcium-induced aggregation. J Biol Chem 264:12,009–12,015, 1989.
  CAS Google Scholar
• Hwang JR, Lindberg I. Inactivation of the 7B2 inhibitory CT peptide depends on a cal study of hormone production and chromogranin localization. Am J Pathol 116:464–472, 1984.
  Google Scholar
• Cohn DV, Elting JJ, Frick M, et al. Selective localization of the parathyroid secretory protein-I/adrenal medulla chromogranin A family in a wide variety of endocrine cells of the rat. Endocrinology 114:1963–1974, 1984.
  Article CAS PubMed Google Scholar
• Sankoorikal BJ, Zhu YL, Hodsdon ME, et al. Aggregation of human wild-type and H27A-prolactin in cells and in solution: roles of Zn2+, Cu2+, and pH. Endocrinology 143:1302–1309 2002.
  Article CAS PubMed Google Scholar
• Watanabe T, Uchiyama Y, Grube D. Topology of chromogranin A and secretogranin II in the rat anterior pituitary: potential marker proteins for distinct secretory pathways in gonadotrophs. Histochemistry 96:285–293, 1991.
  Article CAS PubMed Google Scholar
• Sarac MS, Zieske AW, Lindberg I. The lethal form of Cushing's in 7B2 null mice is caused by multiple metabolic and hormonal abnormalities. Endocrinology 143:2324–2332, 2002.
  CAS PubMed Google Scholar
• Laurent V, Kimble A, Peng B, et al. Mortality in 7B2 null mice can be rescued by adrenalectomy: involvement of dopamine in ACTH hypersecretion. Proc Natl Acad Sci USA 99:3087–3092, 2002.
  Article PubMed Central CAS PubMed Google Scholar
• Chanat E, Huttner WB. Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network. J Cell Biol 115:1505–1519, 1991.
  Article CAS PubMed Google Scholar
• Rosa P, Zanini A. Characterization of adenohypophysial polypeptides by two-dimensional gel electrophoresis. II. Sulfated and glycosylated polypeptides. Mol Cell Endocrinol 24:181–193, 1981.
  Article CAS PubMed Google Scholar
• Fischer-Colbrie R, Laslop A, Kirchmair R. Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin. Prog Neurobiol 46:49–70, 1995.
  Article CAS PubMed Google Scholar
• Settleman J, Nolan J, Angeletti RH. Chromogranin, an integral membrane protein. J Biol Chem 260:1641–1644, 1985.
  CAS PubMed Google Scholar
• Pimplikar SW, Huttner WB. Chromogranin B (secretogranin I), a secretory protein of the regulated pathway, is also p9resent in a tightly membrane-associated form in PC12 cells. J Biol Chem 267:4110–4118, 1992.
  CAS PubMed Google Scholar
• Yoo SH, So SH, Kweon HS, et al. Coupling of the inositol 1,4,5-trisphosphate receptor and chromogranins A and B in secretory granules. J Biol Chem 275:12,553–12,559, 2000
  Article CAS Google Scholar
• Yoo SH. Coupling of the IP3 receptor/Ca2+ channel with Ca2+storage proteins chromogranins A and B in secretory granules. Trends Neurosci 23:424–428, 2000.
  Article CAS PubMed Google Scholar
• Iguchi H, Chan JSD, Seidah NG, et al. Tissue distribution and molecular forms of a novel pituitary protein in the rat. Neuroendocrinology 39:453–458, 1984.
  Article CAS PubMed Google Scholar
• Ottiger H-P, Battenberg EF, Tsou A-P, et al. IB1075: a brain-and pituitary-specific mRNA that encodes a novel chromogranin/secretogranin-like component of intracellular vesicles. J Neurosci 10:3135–3147, 1990.
  CAS PubMed Google Scholar
• Sichia R, Lovisetti-Scamihorn P, Hogue-Angeletti R, et al. Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HTIB receptor antagonist activity. J Biol Chem 272:11,657–11,662, 1997.
  Article Google Scholar
• Fasciotto BH, Gorr S-U, Cohn DV. Autocrine inhibition of parathyroid cell secretion requires proteolytic processing of chromogranin A. Bone Min 17:323–333, 1992.
  Article CAS Google Scholar
• Egger C, Kirchmair R, Hogue-Angeletti R, et al. Different degrees of processing of secretogranin II in large dense core vesicles of bovine adrenal medulla and sympathetic axons correlate with their content of soluble PC1 and PC2. Neurosci Lett 159:199–201, 1993.
  Article CAS PubMed Google Scholar
• Arden SD, Rutherford NG, Guest PC, et al. The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2. Biochem J 298:521–528, 1994.
  Article PubMed Central CAS PubMed Google Scholar
• Laslop A, Weiss C, Savaria D, et al. Proteolytic processing of chromogranin B and secretogran in II by prohormone convertases. J Neurochem 70:374–383, 1998.
  Article CAS PubMed Google Scholar
• Laslop A, Becker A, Lindberg I, et al. Proteolytic processing of chromogranins is modified in brains of transgenic mice. Ann NY Acad Sci 271:49–52, 2002.
  Article Google Scholar
• Stridsberg M, Angeletti RH, Helle KB. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods. J Endocrinol 165:703–714, 2000.
  Article CAS PubMed Google Scholar
• Borch K, Stridsberg M, Burman P, et al. Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis. Scand J Gastroenterol 32:198–202, 1997.
  Article CAS PubMed Google Scholar
• Kirchmair R, Egger C, Gee P, et al. Differential subcellular distribution of PC1, PC2 and furin in bovine adrenal medulla and secretion of PC1 and PC2 from this tissue. Neurosci Lett 143:143–145, 1992.
  Article CAS PubMed Google Scholar
• Winkler H, Fischer-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49:497–528, 1992.
  Article CAS PubMed Google Scholar
• Metz-Boutigue M-H, Garcia-Sablone P, Hogue-Angeletti R, et al. Intracellular and extracellular processing of chromogranin A: determination of cleavage sites. Eur J Biochem 217:247–257, 1993.
  Article CAS PubMed Google Scholar
• Jiang Q, Yasothornsrikul S, Taupenot L, et al. The local chromaffin cell plasminogen/plasmin system and the regulation of catecholamine secretion. Ann NY Acad Sci 971:445–449, 2002.
  Article CAS PubMed Google Scholar
• Fasciotto BH, Denny JC, Greeley GH Jr, et al. Processing of chromogranin A in the parathyroid: generation of parastatin-related peptides. Peptides 21:1389–1401, 2000.
  Article CAS PubMed Google Scholar
• Seidah NG, Hendy GN, Hamelin J, et al. Chromogranin A can act as a reversible processing enzyme inhibitor: evidence from the inhibition of the IRCM-serine protease 1 cleavage of pro-enkephalin and ACTH at pairs of basic amino acids. FEBS Lett 211:144–150, 1987.
  Article CAS PubMed Google Scholar
• Helle KB, Angeletti RH. Chromogranin A: a multipurpose prohormone? Acta Physiol Scand 152:1–10, 1994.
  Article CAS PubMed Google Scholar
• Iacangelo AL, Eiden LE. Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway. Regul Pep 58:65–88, 1995.
  Article CAS Google Scholar
• Helle KB, Metz-Boutigie M-H, Aunis D. Chromogranin A as a calcium-binding precusor for a multitude of regulatory peptides for the immune, endocrine and metabolic systems. Curr Med Chem-Immun Endocr Metab Agents 1:119–140, 2001.
  Article CAS Google Scholar
• Aardal S, Helle KB. The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels. Regul Pep 41:9–18, 1992.
  Article CAS Google Scholar
• Aardal S, Helle KB, Elsayed S, et al. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J Neuroendocrinol 5:405–412, 1993.
  Article CAS PubMed Google Scholar
• Angeletti RH, Aardal S, Serck-Hanssen G, et al. Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A. Acta Physiol Scand 152:11–19, 1994.
  Article CAS PubMed Google Scholar
• Sanchez-Margalet V, Gonzalez-Yanes C, Santos-Alvarez J, et al. Pancreastatin: biological effects and mechanisms of action. Adv Exp Med Biol 482:247–262, 2000.
  Article CAS PubMed Google Scholar
• Sanchez-Margalet V, Gonzalez-Yanes C. Pancreastatin inhibits insulin action in rat adipocytes. Am J Physiol 275:E1055-E1060, 1998.
  CAS PubMed Google Scholar
• Gonzalez-Yanes C, Sanchez-Margalet V. Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk. Diabetes 49:1288–1294, 2000.
  Article CAS PubMed Google Scholar
• Tatemoto K, Efendic S, Mutt V, et al. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324:476–478, 1986.
  Article CAS PubMed Google Scholar
• Taupenot L, Ciesielski-Treska J, Ulrich G, et al. Chromogranin A triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells. Neuroscience 72:377–389, 1996.
  Article CAS PubMed Google Scholar
• Sanchez-Margalet V, Lucas M, Goberna R. Pancreastatin action in the liver: dual coupling to different G proteins. Cell Signal 8:9–12, 1996.
  Article CAS PubMed Google Scholar
• Gonzalez-Yanes C, Santos-Alvarez J, Sanchez-Margalet V. Characterization of pancreastatin receptors and signaling in adipocyte membranes. Biochim Biophys Acta 1451: 153–162, 1999.
  Article CAS PubMed Google Scholar
• Schneitler C, Kahler C, Wiedermann CJ, et al. Specific binding of a 1251-secretoneurin analogue to a human monocytic cell line. J Neuroimmunol 86:87–91, 1998.
  Article CAS PubMed Google Scholar
• Lembo PM, Grazzini E, Groblewski T, et al. Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat Neurosci 5:201–209, 2002.
  Article CAS PubMed Google Scholar
• Rieker S, Fischer-Colbrie R, Eiden L, et al. Phylogenetic distribution of peptides related to chromogranins A and B. J. Neurochem 50:1066–1073, 1988.
  Article CAS PubMed Google Scholar
• Peterson JB, Nelson DL, Ling E, et al. Chromogranin A-like proteins in the secretory granules of a protozoan, Paramecium tetraurelia. J Biol Chem 262:17,264–17,267, 1987.
  CAS Google Scholar
• Brownlee DJA, Fairweather I, Johnston CG, et al. Immunocytochemical demonstration of neuropeptides in the central nervous system of the roundworm, Ascaris suum (Nematoda: Ascaroidea). Parasitology 106:305–316, 1993.
  Article CAS PubMed Google Scholar
• Smart D, Johnston CF, Curry WJ, et al. Immunoreactivity to two specific regions of chromogranin A in the nervous system of Ascaris suum: an immunocytochemical study. Parasitol Res 78:329–335, 1992.
  Article CAS PubMed Google Scholar
• Lindberg I, Tu B, Muller L, et al. Cloning and functional analysis of C. elegans 7B2. DNA Cell Biol 17:727–734, 1998.
  Article CAS PubMed Google Scholar
• Sato F, Kanno T, Nagasawa S, et al. Immunohistochemical localization of chromogranin A in the acinar cells of equine salivary glands contrasts with rodent glands. Cells Tissues Organs 172:29–36, 2002.
  Article CAS PubMed Google Scholar
• Elde R, Haber S, Ho R, et al. Interspecies conservation and variation in peptidergic neurons. Peptides 1:21–26, 1980.
  Article CAS Google Scholar
• Simon J-P, Aunis D. Biochemistry of the chromogranin A protein family. Biochem J 262:1–13, 1989.
  Article PubMed Central CAS PubMed Google Scholar
• Stridsberg M, Husebye ES. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma. Eur J Endocrinol 136:67–73, 1997.
  Article CAS PubMed Google Scholar
• O'Connor DT, Burton D, Deftos LJ. Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues. J Clin Endocrinol Metab 57:1084–1086, 1983.
  Article PubMed Google Scholar
• Lloyd RV, Mervak T, Schmide K, et al. Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms. Am J Surg Pathol 8:607–614, 1984.
  Article CAS PubMed Google Scholar
• O'Connor DT, Burton DW, Parmer RJ, et al., in Cohn DV et al., eds., Endocrine control of bone and calcium metabolism, Amsterdam: Elsevier, 1984; 187–190.
  Google Scholar
• Lloyd RV, Blaivas M, Wilson BS. Distribution of chromogranin and S100 protein in normal and abnormal adrenal medullamy tissues. Arch Pathol Lab Med 109:633–638, 1985.
  CAS PubMed Google Scholar
• Said JW, Vimadalal S, Nash G, et al. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors. Hum Pathol 16:236–240, 1985.
  Article CAS PubMed Google Scholar
• Walts AE, Said JW, Shintaku P, et al. Chromogranin as a marker of neuroendocrine cells in cytologic material—an immunocytochemical study. Am J Clin Pathol 84:273–277, 1985.
  CAS PubMed Google Scholar
• O'Connor DT, Deftos LJ. Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med 314:1145–1151, 1986.
  Article PubMed Google Scholar
• Lloyd RV. Immunohistochemical localization of chromogranin in normal and neoplastic endocrine tissues. Pathol Ann 22:69–90, 1987.
  Google Scholar
• Schmid KW, Fischer-Colbrie R, Hagn C, et al. Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid. Am J Surg Pathol 11:551–556, 1987.
  Article CAS PubMed Google Scholar
• Schober M, Fischer-Colbrie R, Schmid KW, et al. Comparison of chromogranins A, B, and secretogranin II in human adrenal medulla and pheochromocytoma. Lab Invest 57:385–391, 1987.
  CAS PubMed Google Scholar
• Weiler R, Feichtinger H, Schmid KW, et al. Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids. Virchows Arch A Pathol Anat Histopathol 412:103–109, 1987.
  Article CAS PubMed Google Scholar
• Tischler AS, Dayal Y, Balogh K, et al. The distribution of immunoreactive chromogranins, S-100 protein, and vasoactive intestinal peptide in compound tumors of the adrenal medulla. Hum Pathol 18:909–917, 1987.
  Article CAS PubMed Google Scholar
• Weiler R, Fischer-Colbrie R, Schmid KW, et al. Immunological studies on the occurrence and properties of chromogranin A and B and secretogranin II in endocrine tumors. Am J Surg Pathol 12:877–884, 1988.
  Article CAS PubMed Google Scholar
• Schmid KW, Schröder S, Dockhorn-Dworniczak B, et al. Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretogranin I in extra-adrenal paragangliomas. Modern Pathol 7:347–353, 1994.
  CAS Google Scholar
• Ischia R, Culig Z, Eder U, et al. Presence of chromogranins and regulation of their synthesis and processing in a neuroendocrine prostate tumor cell line. Prostate Suppl 8:80–87, 1998.
  Article CAS PubMed Google Scholar
• Hsiao RJ, Seeger RC, Yu AL, O'Connor DT, Chromogranin A in children with neuroblastoma serum concentration parallels disease stage and predicts survival. J Clin Invest 85:1555–1559, 1990.
  Article PubMed Central CAS PubMed Google Scholar
• Eriksson B, Arnberg H, Oberg K, et al. Chromogranins—new sensitive markers for neuroendocrine tumors. Acta Oncol 28: 325–329, 1989.
  Article CAS PubMed Google Scholar
• Yasuda D, Iguchi H, Funakoshi A, et al. Comparison of plasma pancreastatin and GAWK concentrations, presumed procesing products of chromogranin A and B, in plasma of patients with pancreatic islet cell tumors. Horm Metab Res 25:593–595, 1993.
  Article CAS PubMed Google Scholar
• Iguchi H, Hara N, Hayashi I, etal. Elevation of a novel pituitary protein (7B2) in the palsma in small cell carcinoma of the lung. Eur J Cancer Clin Oncol 25:1225–1232, 1989.
  Article CAS PubMed Google Scholar
• Iguchi H, Niida Y, Natori S, etal. Remarkbble changes in the plasma levels of pituir∢ry protein “7B2” during childhood. Peidatr Res 24:194–196, 1988.
  Article CAS Google Scholar
• O'Connor DT, Bernstein KN. Radioimmunoassay of chromogranin A in plasma as ameasure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N Engl J Med 311:764–770, 1984.
  Article PubMed Google Scholar
• Takiyyuddin MA, Brown MR, Dinh TQ, et al. Sympathol-adrenal secretion in humans; factors governing catecholamine and storage vesicle peptide co-release. J Auton Pharmacol 14:187–200, 1994.
  Article CAS PubMed Google Scholar
• Kanno T, Asada N, Yanase H, et al. Salivary secretion of highly concentrated chromogranin a in respone to noradrenaline and acetylcholine in isolated and perfused rat submandibular glands. Exp Physiol 84: 1073–1083, 1999.
  Article CAS PubMed Google Scholar
• Yanaihara N, Kanno T, Asada N, et al. VIP-and PACAP-induced salivary chromogranin A secretion in the isolated perfused submandibular gland of rats. Ann NY Acad Sci 921:218–225, 2000.
  Article CAS PubMed Google Scholar
• Kanno T, Asada N, Yanase H, et al. Salivary secretion of chromogranin A: control by autonomic nervous system. Adv Exp Med Biol 482:143–51, 2000.
  Article CAS PubMed Google Scholar
• Steiner H-J, Weiler R, Ludescher C, et al. Chromogranins A and B are col-localized with atrial natriuretic peptides in secretory granules of rat heart. J Histochem Cytochem 38:845–850, 1990.
  Article CAS PubMed Google Scholar
• Hakanson R, Ding XQ, Norlen P, et al. Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rat stomach. Gastroenterology 108:1445–1452, 1995.
  Article CAS PubMed Google Scholar
• Tateishi K, Funakoshi A, Wakasugi H, et al. Plasma pancreastatin-like immunoreactivity in various diseases. J Clin Endocrinol Metab 69:1305–1308, 1989.
  Article CAS PubMed Google Scholar
• Nielsen E, Welinder BS, Madsen OD. Chromogranin-B, a putative precursor of eight novel rat glucagonoma peptides through procesing at mono-, di-, or tribasic residues. Endocrinology 129:3147–3156, 1991.
  Article CAS PubMed Google Scholar
• Edgren M., Stridsberg M, Kalknar KM, et al. Neuroendocrine markers: chromogranin, pancreastatin and serotonin in the management of patients with advanced renal cell carcinoma. Anticancer Res 16:4871–4874, 1996.
  Google Scholar
• Öberg K. Biology, diagnosis, and treament of neuroendocrine tumors of the gastrointestinal tract. Curr Opin Oncol 6:441–451, 1994.
  Article PubMed Google Scholar
• Falkensammer G, Fischer-Colbrie R, Richter K, et al. Cell-free and cellular synthesi of chromogranin A and B of bovine adrenal medulla. Neuroscience 14:735–746, 1985.
  Article CAS PubMed Google Scholar
• Conn PM, Janovick JA, Braden TD, et al. SIIp: a unique secretogranin/chromogranin of the pituitary released in response to gonadotropin-releasing hormone. Endocrinology 130:3033–3040, 1992.
  CAS PubMed Google Scholar
• Hosaka M, Watanabe T, Sakai Y, et al. Identification of a chromogranin A domain that mediates binding to secretogranin II and targeting to secretory granules in pituitary cells and pancreatic beta-cells. Mol Biol Cell 13:3388–3399, 2002.
  Article PubMed Central CAS PubMed Google Scholar
• Neuhold N, Ullrich R. Secretogranin IV immunoreactivity in medullary thyroid carcinoma: an immunohistochemical study of 62 cases. Virchows Arch A Pathol Anat Histopathol 423:85–89, 1993.
  Article CAS PubMed Google Scholar
• Trani E, Giorgi A, Canu N, et al. Isolation and characterization of VGF peptides in rat brain: role of PC1/3 and PC2 in the maturation of VGF precursor. J Neurochem 81:565–574, 2002
  Article CAS PubMed Google Scholar
• Russell J, Gee P, Liu SM, et al. Inhibition of parathyroid hormone secretion by aminoterminal chromogranin peptides. Endocrinology 135:337–342, 1994.
  CAS PubMed Google Scholar
• Lazure C, Paquet L, Litthauer D, et al. The ostrich pituitary contains a major peptide homologous to mammalian chromogranin A(1–76). Peptides 11:79–87, 1990.
  Article CAS PubMed Google Scholar
• Hutton JC, Davidson HW, Grimaldi KA, et al. Bisynthesis of β-granin in pancreatic β cells. Biochem J 244:449–456, 1987.
  Article PubMed Central CAS PubMed Google Scholar
• Hutton JC, Davidson HW, Peshvaria M. The mechanism of chromogranin A processing. Nature 325:766, 1987.
  Article CAS PubMed Google Scholar
• Drees BM, Rouse J, Johnson J, et al. Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion. Endocrinology 129:3381–3387, 1991.
  Article CAS PubMed Google Scholar
• Drees BM, Hamilton JW. Processing of chromogranin A by bovine parathyroid secretory granules: production and secretion of N-terminal fragments. Endocrinology 134:2057–2063, 1994.
  CAS PubMed Google Scholar
• Sekiya K, Ghatei MA, Minamino N, et al. Isolation of human pancreastatin fragment containing the active sequence from a glucogonoma. FEBS Lett 228:153–156, 1988.
  Article CAS PubMed Google Scholar
• Schmidt WE, Siegel EG, Kratzin H, et al. Isolation and primary structure of tumorderived peptides related to human pancreastatin and chromogranin A. Proc Natl Acad Sci USA 85:8231–8235, 1988.
  Article PubMed Central CAS PubMed Google Scholar
• Nakano I, Funkaoshi A, Miyasaka K, et al. Isolation and characterization of bovine pancreastatin. Regul Pep 25:207–213, 1989.
  Article CAS Google Scholar
• Efendic S, Tatemoto K, Mutt V, et al. Pancreastatin and islet hormone release. Proc Natl Acad Sci USA 84:7257–7260, 1987.
  Article PubMed Central CAS PubMed Google Scholar
• Ahren B, Lindskog S, Tatemoto K, et al. Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice. Dibetes 37:281–285, 1988.
  Article CAS Google Scholar
• Ishizuka J, Asada I, Poston GJ, et al. Effect of pancreastatin on pancreatic endocrine and exocrine secretion. Pancres 4:277–281, 1989.
  Article CAS Google Scholar
• Lewis JJ, Zdon MJ, Adrian TE, et al. Pancreastatin: a novel peptide inhibitor of parietal cell secretion. Surgery 104:1031–1036, 1988.
  CAS PubMed Google Scholar
• Lewis JJ, Goldenring JR, Asher VA, et al. Pancreastatin: a novel peptide inhibitor of pariental cell signal tranduction. Biochem Biophys Res Commun 163:667–673, 1989.
  Article CAS PubMed Google Scholar
• Drees BM, Hamilton JW. Pancreastatin and bovine parathyroid cell secretion. Bone Miner 17:335–346, 1992.
  Article CAS PubMed Google Scholar
• Fasciotto BH, Gorr S-U, DeFranco DJ, et al. Pancreastatin, a presumed product of chromogranin-A (secretory protrein-I procesing, inhibitis secretion from procine parathyroid cells in culture. Endocrinology 125:1617–1622, 1989.
  Article CAS PubMed Google Scholar
• Zhang J-X, Fasciotto BH, Darling DS, et al. Pancreastatin, a chromograin A-derived peptide, inhibits transcription of the parathyroid hormone and chromogranin A genes and decreases the stability of the respective mesenger ribonucleic acids in parathyroid cells in culture. Endocrinology 134:1310–1316, 1994.
  CAS PubMed Google Scholar
• Funakoshi A, Miyasaka K, Kitani K, et al. Comparative effects of mammalian pancreastatins on the pancreatic exocrine secretion. Jpn J Physiol 39:901–905, 1989.
  Article CAS PubMed Google Scholar
• Sanchez-Margalet V, Goberna R Pancreastatin decreases plasma epinephrine levels in surgical stress in the rat. Peptides 14:797–799, 1993.
  Article CAS PubMed Google Scholar
• Curry WJ, Shaw C, Johnston CF, et al. Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour. FEBS Lett 301:319–321, 1992.
  Article CAS PubMed Google Scholar
• Forsythe P, Curry WJ, Johnston CF, et al. The modulatory effects of WE-14 on histamine release from rat peritoneal mast cells. Inflamm Res 46(Suppl 1):S13, S14, 1997.
  Article Google Scholar
• Tsigelny I, Mahata SK, Taupenot L, et al. Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beeta-strand structure secured by hydrophobic interactions and predictive of activity. Regul Rept 77:43–53, 1998.
  Article CAS Google Scholar
• Taupenot L, Mahata SK, Mahata M, et al. Interaction of the catecholamine releaseinhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism. Regul Pept 95:9–17, 2000.
  Article CAS PubMed Google Scholar
• Kennedy BP, Mahata SK, O'Connor DT, et al. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides 19:1241–1248, 1998.
  Article CAS PubMed Google Scholar
• Mahata SK, Mahata M, Wakade AR, et al. Primary structure and function of the carecholamine release inhibitory peptide catestatin (chromogranin A344–364): identification of amino acid residues crucial for activity. Mol Endocrinol 14:1525–1535, 2000.
  CAS PubMed Google Scholar
• Strub JM, Guomon Y, Lugardon K, et al. Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173–194 from bovine adrenal medullary chromaffin granules. J Biol Chem 271:28,533–28,540, 1996.
  Article CAS Google Scholar
• Funakoshi A, Jimi A, Yasunami Y, et al. Bioactivity of human pancreastatin and its localization in pancreas. Biochem Biophys Res Commun 159:913–918, 1989.
  Article CAS PubMed Google Scholar
• Fasciotto BH, Trauss CA, Greeley GH, Cohn DV. Parastatin (porcine chromogranin A347.419), a novel chromogranin Aderived peptide, inhibits parathyroid cell secretion. Endocrinology 133:461–466, 1993.
  CAS PubMed Google Scholar